|
⚲
|
| Keyboard |
| Daniel Cain | |
|---|---|
| Firm | HEP Management Corporation |
| Address | c/o Hep Associates II LLC 565 Fifth Avenue, 26th Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| HEP Management Corporation | |||||
| Health Enterprise Partners II LP | 021-182083 | Executive Officer | 136.4 M of 136.4 M |
37.0 M | |
| Repros Therapeutics Inc | 021-184301 | Director | 23.6 M of 23.6 M |
||
| Cain Brothers & Co Inc | 021-167162 | Director | 1.4 M of 2.1 M |
||
| Repros Therapeutics Inc | 021-89707-5F | Director | 5.9 M of 6.1 M |
||
| CB Health Management Corporation | |||||
| CB Healthcare Fund II LP | 021-128393 | Promoter | 3.1 M of 8.0 M |
19.8 M | |